Telomerase and breast cancer

Brittney-Shea Herbert, W. E. Wright, J. W. Shay

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in normal adjacent tissues. Telomerase is thus an attractive target for both diagnosis and therapy because of its distinct pattern of expression. We address the use of telomerase in the diagnostics of breast pathology, as well as the use of telomerase inhibitors in the treatment and prevention of breast cancer.

Original languageEnglish (US)
Pages (from-to)146-149
Number of pages4
JournalBreast Cancer Research
Volume3
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Telomerase
Breast Neoplasms
Poisons
RNA-Directed DNA Polymerase
Telomere
Drug Resistance
Breast
Chromosomes
Pathology
Therapeutics

Keywords

  • Breast cancer
  • Inhibitors
  • Telomeres
  • Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Telomerase and breast cancer. / Herbert, Brittney-Shea; Wright, W. E.; Shay, J. W.

In: Breast Cancer Research, Vol. 3, No. 3, 2001, p. 146-149.

Research output: Contribution to journalArticle

Herbert, B-S, Wright, WE & Shay, JW 2001, 'Telomerase and breast cancer', Breast Cancer Research, vol. 3, no. 3, pp. 146-149. https://doi.org/10.1186/bcr288
Herbert, Brittney-Shea ; Wright, W. E. ; Shay, J. W. / Telomerase and breast cancer. In: Breast Cancer Research. 2001 ; Vol. 3, No. 3. pp. 146-149.
@article{b4def7ca20384082b1a543a9df799339,
title = "Telomerase and breast cancer",
abstract = "Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90{\%} of breast carcinomas) but not in normal adjacent tissues. Telomerase is thus an attractive target for both diagnosis and therapy because of its distinct pattern of expression. We address the use of telomerase in the diagnostics of breast pathology, as well as the use of telomerase inhibitors in the treatment and prevention of breast cancer.",
keywords = "Breast cancer, Inhibitors, Telomeres, Therapy",
author = "Brittney-Shea Herbert and Wright, {W. E.} and Shay, {J. W.}",
year = "2001",
doi = "10.1186/bcr288",
language = "English (US)",
volume = "3",
pages = "146--149",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "3",

}

TY - JOUR

T1 - Telomerase and breast cancer

AU - Herbert, Brittney-Shea

AU - Wright, W. E.

AU - Shay, J. W.

PY - 2001

Y1 - 2001

N2 - Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in normal adjacent tissues. Telomerase is thus an attractive target for both diagnosis and therapy because of its distinct pattern of expression. We address the use of telomerase in the diagnostics of breast pathology, as well as the use of telomerase inhibitors in the treatment and prevention of breast cancer.

AB - Current therapies for breast cancer include treatments that are toxic and often result in drug resistance. Telomerase, a cellular reverse transcriptase that maintains the ends of chromosomes (telomeres), is activated in the vast majority of breast cancers (over 90% of breast carcinomas) but not in normal adjacent tissues. Telomerase is thus an attractive target for both diagnosis and therapy because of its distinct pattern of expression. We address the use of telomerase in the diagnostics of breast pathology, as well as the use of telomerase inhibitors in the treatment and prevention of breast cancer.

KW - Breast cancer

KW - Inhibitors

KW - Telomeres

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0035033860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035033860&partnerID=8YFLogxK

U2 - 10.1186/bcr288

DO - 10.1186/bcr288

M3 - Article

VL - 3

SP - 146

EP - 149

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 3

ER -